154 related articles for article (PubMed ID: 222207)
1. Pharmacological evidence about nigro-striatal inhibition related to intrinsic GABA in the caudate nucleus deprived of dopaminergic synaptic activity.
Feltz P
Appl Neurophysiol; 1979; 42(1-2):47-50. PubMed ID: 222207
[No Abstract] [Full Text] [Related]
2. Substantia nigra as a station that not only transmits, but also transforms, incoming signals for its behavioural expression: striatal dopamine and GABA-mediated responses of pars reticulata neurons.
Cools AR; Jaspers R; Kolasiewicz W; Sontag KH; Wolfarth S
Behav Brain Res; 1983 Jan; 7(1):39-49. PubMed ID: 6297521
[No Abstract] [Full Text] [Related]
3. Regulation of nigro-striatal dopaminergic neurotransmission in the rat.
Dray A; Fowler LJ; Oakley NR; Simmonds MA; Tanner T
Neuropharmacology; 1977; 16(7-8):511-8. PubMed ID: 199852
[No Abstract] [Full Text] [Related]
4. [Stereotyped behavior and the nigro-strio-nigral system].
Arushanian EB
Zh Vyssh Nerv Deiat Im I P Pavlova; 1985; 35(5):819-32. PubMed ID: 2866641
[No Abstract] [Full Text] [Related]
5. The susceptibility to acetylcholine and dopamine in the caudate nucleus of cats with chronic nigrostriatal lesions.
Sphelmann R
Trans Am Neurol Assoc; 1974; 99():255-7. PubMed ID: 4156892
[No Abstract] [Full Text] [Related]
6. Activation of D1 dopamine receptors stimulates the release of GABA in the basal ganglia of the rat.
Floran B; Aceves J; Sierra A; Martinez-Fong D
Neurosci Lett; 1990 Aug; 116(1-2):136-40. PubMed ID: 2147981
[TBL] [Abstract][Full Text] [Related]
7. Role of the dendritic release of dopamine in the reciprocal control of the two nigro-striatal dopaminergic pathways.
Leviel V; Chéramy A; Glowinski J
Nature; 1979 Jul; 280(5719):236-9. PubMed ID: 450141
[No Abstract] [Full Text] [Related]
8. Experimental basis of the therapy of Parkinson's disease and the cholinergic-dopaminergic equilibrium in basal brain nuclei.
Wolfarth S
Pol J Pharmacol Pharm; 1976; 28(5):469-93. PubMed ID: 796834
[No Abstract] [Full Text] [Related]
9. The effects of ethanolamine-O-sulphate injection into the rat substantia nigra: electrophysiological studies.
Oakley NR; Dray A
Brain Res; 1978 Sep; 153(2):387-91. PubMed ID: 210885
[No Abstract] [Full Text] [Related]
10. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo.
Paladini CA; Celada P; Tepper JM
Neuroscience; 1999 Mar; 89(3):799-812. PubMed ID: 10199614
[TBL] [Abstract][Full Text] [Related]
11. Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications.
Gale K; Casu M
Mol Cell Biochem; 1981 Sep; 39():369-405. PubMed ID: 6118827
[No Abstract] [Full Text] [Related]
12. In vivo measurement of [3H]GABA release: an approach to the study of the regulation of GABA-containing neurons in the basal ganglia and associated structures in the cat and the rat.
Besson MJ; Kemel ML; Gauchy C; Girault JA; Spampinato U; Lantin N; Desban M; Glowinski J
Ann N Y Acad Sci; 1986; 473():475-88. PubMed ID: 3541740
[No Abstract] [Full Text] [Related]
13. Functional aspects of, and the role of transmitter in, the basal ganglia.
Yoshida M
Confin Neurol; 1974; 36(4-6):282-91. PubMed ID: 4156664
[No Abstract] [Full Text] [Related]
14. The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral GABAergic pathway.
Olianas MC; De Montis GM; Mulas G; Tagliamonte A
Eur J Pharmacol; 1978 Jun; 49(3):233-41. PubMed ID: 566207
[No Abstract] [Full Text] [Related]
15. Effects of the unilateral nigral modulation of substance P transmission on the activity of the two nigro-striatal dopaminergic pathways.
Michelot R; Leviel V; Giorguieff-Chesselet MF; Chéramy A; Glowinski J
Life Sci; 1979 Feb; 24(8):715-23. PubMed ID: 86931
[No Abstract] [Full Text] [Related]
16. Functional interaction between rat substantia nigra and striatum: GABA and dopamine interrelation.
Racagni G; Bruno F; Cattabeni F; Maggi A; Di Giulio AM; Parenti M; Groppetti A
Brain Res; 1977 Oct; 134(2):353-8. PubMed ID: 890495
[No Abstract] [Full Text] [Related]
17. Substantia nigra as an out-put station for striatal dopaminergic responses: role of a GABA-mediated inhibition of pars reticulata neurons.
Di Chiara G; Porceddu ML; Morelli M; Mulas ML; Gessa GL
Naunyn Schmiedebergs Arch Pharmacol; 1979 Mar; 306(2):153-9. PubMed ID: 571967
[TBL] [Abstract][Full Text] [Related]
18. Stimulation by dopamine of adenosine cyclic 3',5'-monophosphate formation in rat caudate nucleus: effect of lesions of the nigro-neostriatal pathway.
Krueger BK; Forn J; Walters JR; Roth RH; Greengard P
Mol Pharmacol; 1976 Jul; 12(4):639-48. PubMed ID: 183096
[No Abstract] [Full Text] [Related]
19. Some neuroactive compounds in the substantia nigra.
Krnjević K
Adv Neurol; 1974; 5():145-52. PubMed ID: 4155230
[No Abstract] [Full Text] [Related]
20. GABA in the caudate nucleus: a possible synaptic transmitter of interneurons.
Spehlmann R; Norcross K; Grimmer EJ
Experientia; 1977 May; 33(5):623-5. PubMed ID: 193718
[No Abstract] [Full Text] [Related]
[Next] [New Search]
